Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$34.1M Buy
474,935
+16,081
+4% +$1.51M 0.15% 139
2026
Q1
$54.2M Sell
458,854
-67,878
-13% -$8.39M 0.28% 80
2025
Q4
$66.3M Sell
526,732
-257,613
-33% -$33.6M 0.33% 67
2025
Q3
$115M Buy
784,345
+189,505
+32% +$28.6M 0.6% 32
2025
Q2
$92.8M Buy
594,840
+96,079
+19% +$15.2M 0.53% 35
2025
Q1
$82.1M Buy
498,761
+395
+0.1% +$65.7K 0.51% 37
2024
Q4
$81.2M Sell
498,366
-55,974
-10% -$10M 0.47% 43
2024
Q3
$108M Buy
554,340
+183,100
+49% +$33.7M 0.62% 31
2024
Q2
$64.4M Buy
371,240
+59,943
+19% +$9.98M 0.39% 55
2024
Q1
$52.7M Buy
311,297
+100,125
+47% +$18.8M 0.34% 67
2023
Q4
$41.7M Buy
211,172
+166,731
+375% +$29.5M 0.29% 85
2023
Q3
$7.73M Buy
44,441
+1,476
+3% +$268K 0.05% 259
2023
Q2
$7.4M Sell
42,965
-28,337
-40% -$4.9M 0.05% 286
2023
Q1
$10.9M Sell
71,302
-21,624
-23% -$3.54M 0.08% 248
2022
Q4
$13.6M Buy
92,926
+9,315
+11% +$1.38M 0.09% 216
2022
Q3
$12.4M Buy
83,611
+46,319
+124% +$7.74M 0.09% 225
2022
Q2
$6.41M Sell
37,292
-14,289
-28% -$2.47M 0.05% 291
2022
Q1
$9.73M Buy
51,581
+1,914
+4% +$378K 0.07% 262
2021
Q4
$12.1M Sell
49,667
-3,513
-7% -$769K 0.08% 235
2021
Q3
$10.3M Sell
53,180
-636
-1% -$128K 0.07% 268
2021
Q2
$10M Buy
53,816
+18,437
+52% +$3.2M 0.07% 283
2021
Q1
$5.62M Hold
35,379
0.05% 351
2020
Q4
$5.86M Buy
35,379
+5,187
+17% +$844K 0.05% 360
2020
Q3
$4.99M Sell
30,192
-2,053
-6% -$315K 0.05% 353
2020
Q2
$4.42M Sell
32,245
-10,137
-24% -$1.32M 0.05% 359
2020
Q1
$5.48M Hold
42,382
0.06% 325
2019
Q4
$5.61M Buy
42,382
+672
+2% +$83.5K 0.06% 331
2019
Q3
$5.2M Buy
41,710
+834
+2% +$101K 0.07% 307
2019
Q2
$4.62M Sell
40,876
-1,337
-3% -$140K 0.06% 345
2019
Q1
$4.25M Sell
42,213
-7,421
-15% -$674K 0.05% 357
2018
Q4
$4.25M Buy
49,634
+1,947
+4% +$175K 0.07% 315
2018
Q3
$4.37M Sell
47,687
-1,056
-2% -$93.7K 0.06% 347
2018
Q2
$4.15M Sell
48,743
-2,069
-4% -$175K 0.07% 333
2018
Q1
$4.24M Sell
50,812
-473
-0.9% -$37.3K 0.07% 319
2017
Q4
$3.69M Buy
51,285
+122
+0.2% +$8.38K 0.06% 327
2017
Q3
$3.26M Buy
51,163
+3,943
+8% +$247K 0.06% 358
2017
Q2
$2.95M Sell
47,220
-116
-0.2% -$6.85K 0.06% 387
2017
Q1
$2.53M Buy
47,336
+9,281
+24% +$502K 0.05% 398
2016
Q4
$2.04M Buy
38,055
+2,976
+8% +$151K 0.05% 366
2016
Q3
$1.82M Buy
35,079
+8,030
+30% +$406K 0.04% 374
2016
Q2
$1.28M Sell
27,049
-28,036
-51% -$1.32M 0.03% 390
2016
Q1
$2.43M Buy
55,085
+8,826
+19% +$375K 0.06% 295
2015
Q4
$2.22M Sell
46,259
-7,266
-14% -$328K 0.06% 282
2015
Q3
$2.2M Buy
53,525
+11,135
+26% +$516K 0.05% 324
2015
Q2
$2.04M Sell
42,390
-141,005
-77% -$6.73M 0.04% 361
2015
Q1
$8.49M Buy
183,395
+128,929
+237% +$5.81M 0.17% 169
2014
Q4
$2.34M Buy
+54,466
New +$2.21M 0.05% 339

Other funds holding ZTS

Candriam SCA's ZTS Position: Q2 2026 in Review

Candriam SCA increased its Zoetis (ZTS) stake by 3.5% in Q2 2026, buying an estimated $1.51M and bringing the position to 474,935 shares worth $34.1M. The position accounts for 0.15% of the portfolio, ranked #139.

Candriam SCA first reported a position in ZTS in Q4 2014 and has held it in 47 quarters since. The position peaked at $115M in Q3 2025. 1,427 funds tracked by Wall St. Rank hold ZTS as of Q2 2026.

  • Candriam SCA held 474,935 shares of Zoetis worth $34.1M as of Q2 2026.
  • Candriam SCA bought 16,081 Zoetis shares in Q2 2026, an estimated $1.51M.
  • Zoetis made up 0.15% of Candriam SCA's portfolio in Q2 2026, its #139 holding.
  • Candriam SCA first reported a position in Zoetis in Q4 2014 and has held it in 47 quarters since.
  • Candriam SCA's Zoetis position peaked at $115M in Q3 2025.
  • 1,427 funds tracked by Wall St. Rank held Zoetis as of Q2 2026.

Based on Candriam SCA's 13F filing for Q2 2026, filed 13 Aug 2026.